Vag (Adults ): Insert one vaginal insert at bedtime.
US Brand Names⬆⬇
Intrarosa
Action⬆⬇
Inactive steroid that is converted into active androgens and/or estrogens. Exact mechanism in treatment of vulvar and vaginal atrophy in menopausal women not fully established.
Therapeutic effects:
Reduced severity of dyspareunia.
Classifications⬆⬇
Therapeutic Classification: none assigned
Pharmacologic Classification: steroids
Pharmacokinetics⬆⬇
Absorption: Unknown.
Distribution: Unknown.
Metabolism/Excretion: Metabolized via dehydrogenase, reductase, and aromatase to estradiol and testosterone.
Half-Life: Unknown.
Time/Action Profile⬆⬇
(↓ in severity of dyspareunia)
ROUTE
ONSET
PEAK
DURATION
Vag
unknown
12 wk
unknown
Patient/Family Teaching⬆⬇
Explain purpose and side effects of medication. Advise patient to read Patient Information before starting therapy.
Inform patient that vaginal discharge and abnormal PAP smear findings may occur with therapy.
Advise patient to notify health care provider of all Rx or OTC medications, vitamins, or herbal products being taken and to consult with health care provider before taking other medications during therapy.
Pronunciation⬆⬇
PRAS-ter-one
Code⬆
NDC Code
51927- Professional Compounding Centers of America dba PCCA
